About HIPRA
HIPRA is a company based in Amer (Spain) founded in 1996.. The company has 22 employees as of April 06, 2024. HIPRA has completed 1 acquisition, including GoodGut. HIPRA operates in a competitive market with competitors including Pardes Biosciences, ExeVir Bio, Inimmune, Vaxxinity and Alchemab, among others.
- Headquarter Amer, Spain
- Employees 22 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hipra India Private Limited
- Date of Incorporation 14 Feb, 2012
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$2.03 M (USD)27.25as on Mar 31, 2023
-
Net Profit
$-576.99 K (USD)-24.72as on Mar 31, 2023
-
EBITDA
$-575.87 K (USD)-24.83as on Mar 31, 2023
-
Latest Funding Round
$2.35 M (USD), Grant
Dec 01, 2021
- Investors
-
Employee Count
22
as on Apr 06, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
45 people
R Team
20 people
Sales and Marketing
18 people
Product Management Team
11 people
Leadership Team
10 people
Regulatory Team
8 people
Data Analysis and Operations Team
3 people
Key Team
2 people
Unlock access to complete
Funding Insights of HIPRA
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $2.3M
-
First Round
First Round
(01 Dec 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Grant - HIPRA | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HIPRA
HIPRA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HIPRA
HIPRA has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GoodGut. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - HIPRA
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hipra Comparisons
Competitors of HIPRA
HIPRA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pardes Biosciences, ExeVir Bio, Inimmune, Vaxxinity and Alchemab, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for pandemic diseases including SARS-CoV-2 are developed.
|
|
| domain | founded_year | HQ Location |
Provider of antibody-based therapies to monitor viral infections
|
|
| domain | founded_year | HQ Location |
Integrated clinical developmental services to treat food allergy, allergic rhinitis, and auto-immune disorders
|
|
| domain | founded_year | HQ Location |
Vaccines for neurological disorders and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for cancer and COVID-19 are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hipra
Frequently Asked Questions about HIPRA
When was HIPRA founded?
HIPRA was founded in 1996 and raised its 1st funding round 25 years after it was founded.
Where is HIPRA located?
HIPRA is headquartered in Amer, Spain. It is registered at Amer, Cataluna, Spain.
How many employees does HIPRA have?
As of Apr 06, 2024, the latest employee count at HIPRA is 22.
What is the annual revenue of HIPRA?
Annual revenue of HIPRA is $2.03M as on Mar 31, 2023.
What does HIPRA do?
HIPRA was established in 1996 in Amer, Spain, within the animal health sector. Vaccines are produced for conditions such as viral nervous necrosis, bursal disease, and respiratory syncytial virus. Diagnostic kits are offered for detection and quantification of pathogens including mycoplasma hyopneumoniae and Leishmania donovani infantum. Operations focus on veterinary applications, with services extending to various animal species across international markets.
Who are the top competitors of HIPRA?
HIPRA's top competitors include Ethris, ExeVir Bio and Alchemab.
How many acquisitions has HIPRA made?
HIPRA has made 1 acquisition, including GoodGut.
Who are HIPRA's investors?
HIPRA has 1 investor. Key investors include European Union.